GlaxoSmithkline Consumer Healthcare fell 2.73% to Rs 5,920 at 9:20 IST on BSE after net profit fell 8.18% to Rs 180.68 crore on 9.6% decline in net sales to Rs 1052.83 crore in Q4 March 2016 over Q4 March 2015.
The result was announced after market hours yesterday, 17 May 2016.Meanwhile, the BSE Sensex was down 176.22 points, or 0.68%, to 25,597.39.
On BSE, so far 47 shares were traded in the counter, compared with an average volume of 4786 shares in the past one quarter. The stock hit a high of Rs 5,950 and a low of Rs 5,800 so far during the day. The stock hit a 52-week high of Rs 6,800 on 22 December 2015. The stock hit a 52-week low of Rs 5,366.50 on 2 March 2016. The stock had outperformed the market over the past one month till 17 May 2016, rising 1.15% compared with 0.57% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 9.15% as against Sensex's 10.23% rise.
The large-cap company has an equity capital of Rs 42.06 crore. Face value per share is Rs 10.
Net profit of GlaxoSmithkline Consumer Healthcare (GSK Consumer Healthcare) rose 17.70% to Rs 686.91 crore on 0.72% decline in net sales to Rs 4106.61 crore in the year ended March 2016 over the year ended March 2015.
GSK Consumer Healthcare is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.
Powered by Capital Market - Live News
